Figures & data
Figure 1 Timeline to summarize the case history of the patient admission, treatment, and isolate collection.
![Figure 1 Timeline to summarize the case history of the patient admission, treatment, and isolate collection.](/cms/asset/857fa9ce-c4a4-4a10-b18f-350f44448d15/didr_a_12156054_f0001_c.jpg)
Table 1 Antimicrobial Susceptibility Test of Six Klebsiella pneumoniae Isolates
Figure 2 Determination of carbapenem resistance of the KP strains by measuring carbapenemase activity using NG-test CARBA 5 kit (A), and carbapenem resistance genes using PCR (B). C: positive control, K: KPC, O: OXA-48-like, V: VIM, I: IMP, N: NDM.
![Figure 2 Determination of carbapenem resistance of the KP strains by measuring carbapenemase activity using NG-test CARBA 5 kit (A), and carbapenem resistance genes using PCR (B). C: positive control, K: KPC, O: OXA-48-like, V: VIM, I: IMP, N: NDM.](/cms/asset/978bb276-c03a-42b6-b411-7bf88064ce59/didr_a_12156054_f0002_c.jpg)
Table 2 Summary of the Genetic and Phenotypic Profiles of the Klebsiella pneumoniae Isolates
Table 3 Viable Counts (CFU/mL) and Percentage of Living Colonies in Serum Killing Assay
Figure 4 Logarithmic calculation of viable colony counts (CFU/mL) of the KP strains subjected to co-incubation with pooled healthy serum for three hours. The values were expressed in the form of mean ± error, and log 10 was used for logarithmic conversion to simplify the data.
![Figure 4 Logarithmic calculation of viable colony counts (CFU/mL) of the KP strains subjected to co-incubation with pooled healthy serum for three hours. The values were expressed in the form of mean ± error, and log 10 was used for logarithmic conversion to simplify the data.](/cms/asset/8541bf2e-0159-4038-81ed-7a7653ba5e67/didr_a_12156054_f0004_c.jpg)